BioNTech, Pfizer could deliver Omicron-adapted COVID-19 vaccines in October

BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron subvariants BA.1 and BA.4/5, which could be ready for fall boosters as early as October.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this